BioCentury
ARTICLE | Company News

PTH and Celentis in cloning venture

December 14, 2000 8:00 AM UTC

PPL Therapeutics (LSE:PTH) entered into a joint venture with Celentis ( Hamilton, New Zealand), the commercial arm of AgResearch, a New Zealand government research institute. The companies will focus ...